Skip to main content
64°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Novartis AG
Roche Holding AG
GSK plc
From
CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
July 21, 2025
Tags
Breaking News: Business
Biotechnology
Business
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Health care industry
Health & Science
Breaking News: Markets
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Breaking News: Earnings
Pharmaceuticals
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
Tags
Politics
Business News
Business
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Health care industry
Health & Science
Eisai Co Ltd
From
CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
GSK plc
New York Times Co
DR Horton Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Starbucks Corp
Peloton Interactive Inc
Snap Inc
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Netflix Inc
Dover Corp
Trane Technologies PLC
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Business
Technology
Politics
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Pharmaceuticals
US: News
Biogen Inc
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Health & Science
Companies
Eisai Co Ltd
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Business
Business News
Investment Strategy
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Kratos Defense and Security Solutions Inc
S&P 500
Bank of America Corp
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
US: News
Pharmaceuticals
Biogen Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Capital One Financial Corp
Meta Platforms Inc
JetBlue Airways Corp
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Biotech and Pharmaceuticals
Business News
Biotechnology
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Eisai Co Ltd
Biogen Inc
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Business
Biotechnology
Earnings
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Investment strategy
DoorDash Inc
Biogen Inc
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Health & Science
Companies
Eisai Co Ltd
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Health care industry
Health & Science
Eisai Co Ltd
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Investment strategy
Uber Technologies Inc
Biogen Inc
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
US: News
Pharmaceuticals
Biogen Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Procter & Gamble Co
AstraZeneca PLC
Breaking news
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.